SML0522

JM6

≥97% (HPLC)

• Sinónimos: 2-(3,4-Dimethoxybenzenesulfonylamino)-4-(3-nitrophenyl)-5-(piperidin-1-yl)methylthiazole, 3,4-Dimethoxy-N-[4-(3-nitrophenyl)-5-(1-piperidinylmethyl)-2-thiazolyl]-benzenesulfonamide
• Fórmula empírica (notación de Hill): C₂₃H₂₆N₄O₆S₂
• Número CAS: 1008119-83-2
• Peso molecular: 518.61
• NACRES: NA.77
• PubChem Substance ID: 329825529
• UNSPSC Code: 12352200
• MDL number: MFCD22380618
• Assay: ≥97% (HPLC)
• Form: powder

Propiedades

• Quality Segment: 100
• assay: ≥97% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 2 mg/mL (clear solution, warmed)
• storage temp.: 2-8°C
• SMILES string: COc1ccc(cc1OC)S(=O)(=O)Nc2nc(c(CN3CCCCC3)s2)-c4cccc(c4)[N+]([O-])=O
• InChI: 1S/C23H26N4O6S2/c1-32-19-10-9-18(14-20(19)33-2)35(30,31)25-23-24-22(16-7-6-8-17(13-16)27(28)29)21(34-23)15-26-11-4-3-5-12-26/h6-10,13-14H,3-5,11-12,15H2,1-2H3,(H,24,25)
• InChI key: AOZLMMDVJOGGEQ-UHFFFAOYSA-N

Descripción

Biochem/physiol Actions

JM6 is a prodrug inhibitor of kynurenine 3-monooxygenase (KMO) that increases kynurenic acid levels and reduces extracellular glutamate in the brain. JM6 prevents spatial memory deficits, anxiety-related behavior, and synaptic loss in mouse model of Alzheimer disease.

JM6 is a prodrug inhibitor of kynurenine 3-monooxygenase (KMO); Ro 61-8048 analog.

Features and Benefits

This compound is featured on the Glutamate Receptors (Ion Channel Family) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Información de seguridad

• Clase de almacenamiento: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable